Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-22-002502
Accepted
2022-08-26 00:15:12
Documents
1
Effectiveness Date
2022-08-25
Registration Form
S-3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 596
  Complete submission text file 9999999995-22-002502.txt   1713
Mailing Address 93 WORCESTER STREET WELLESLEY MA 02481
Business Address 570 PRESTON ST. SUITE 400 LOUISVILLE KY 40202 502-398-9250
Talaris Therapeutics, Inc. (Filer) CIK: 0001827506 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-266875 | Film No.: 221199359
SIC: 2836 Biological Products, (No Diagnostic Substances)